Abstract
Henoch–Schonlein purpura (HSP) is the most common systemic vasculitis in children. Although long-term outcome is generally good, serious complications may occur. Thrombosis has been reported only as an extremely rare complication of HSP. Here, we describe a 15-year-old-boy with features of HSP, who developed left main iliac, external iliac and femoral vein thrombosis. Factor VIII (FVIII) and homocystein levels were found to be high. This suggests that HSP itself may lead to a prothrombotic state and increase the risk of developing thrombosis in patients who have any risk factors.
This is a preview of subscription content, log in via an institution to check access.
References
Garber ME, Mahr BE, Calabrese LH (1993) Henoch–Schonlein purpura associated with anti-Ro (SSA) and antiphospholipid antibody syndrome. J Rheumatol 20:1964–1966
Sokol DK, Mclntyre JA, Short RA, Gutt J, Wagenknecht DR, Biller J, Garg B (2000) Henoch–Schonlein purpura and stroke: antiphosphatdylethanolamine antibody in CSF and serum. Neurology 55:1379–1381
Sari I, Akar S, Secil M, Birlik M, Kefi A, Onen F, Celebi I, Akkoc N (2005) Thrombosis and priapism in a patient with Henoch–Schonlein purpura. Rheumatol Int 25:472–474
Kamitsuji H, Tani K, Yasui M, Taniguchi A, Taira K, Tsukada S, Iida Y, Kanki H, Fukui H (1987) Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch–Schonlein purpura. Eur J Pediatr 146:519–523
Culic S, Jakl R, Metlicic V, Paukovic-Sekulic B, Resic B, Culic V, Kuljis D, Primorac D (2001) Platelet function analysis in children with Schonlein–Henoch syndrome. Arch Med Res 32:268–272
De Mattia D, Penza R, Giardano P, Del Vecchio GC, Aceto G, Altomare M, Schettini F (1995) von Willebrand factor and factor XIII in children with Henoch–Schonlein purpura. Pediatr Nephrol 9:603–605
Prandota J, Pankow-Prandota L, Kotecki L (2001) Impaired activation of the fibrinolytic system in children with Henoch–Schonlein purpura: beneficial effect of hydrocortisone plus Sigma-aminocaproic acid therapy on disappearance rate of cutaneous vasculitis and fibrinolysis. Am J Ther 8:11–19
Brendel-Muller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation is common in Henoch-purpura. Pediatr Nephrol 16:1084–1088
Besbas N, Erbay A, Saatci U (1998) Thrombomodulin, tissue plasminogen activator and plasminogen activator inhibitor-1 in Henoch-purpura. Clin Exp Rheumatol 16:95–98
Yilmaz D, Kavakli K, Ozkayin N (2005) The elevated markers of hypercoagulability in childrenwith Henoch–Schonlein purpura. Pediatr Hematol Oncol 22:41–48
Ates E, Bakkaloglu A, Saatci U, Soylemezoglu O (1994) von Willebrand factor antigen compared with other factors in vasculitic syndromes. Arch Dis Child 70:40–43
Kiraz S, Ertemli I, Ozturk MA, Haznedaroglu IC, Celik I, Calguneri M (2002) Pathological Haemostasis and ‘protrombotic state’ in Behcet’s Disease. Thromb Res 105:125–133
Kurekci AE, Gokce H, Akar N (2003) Factor VIII levels in children with thrombosis. Pediatr Int 45:159–162
Rosendaal FR (2000) High levels of factor VIII, venous thrombosis. Thromb Haemost 83:1–2
Selhub J, D’Angelo A (1997) Hyperhomocysteinemia and thrombosis: Acquired conditions. Thromb Haemost 78:527–531
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Topaloglu, R., Bayrakci, U.S., Cil, B. et al. Henoch–Schonlein purpura with high factor VIII levels and deep venous thrombosis: an association or coincidence?. Rheumatol Int 28, 935–937 (2008). https://doi.org/10.1007/s00296-008-0542-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-008-0542-7